EC5026: Clinical Trials

1 trial of EC5026, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow EC5026: new trials by email Literature Review of EC5026 trials Research Report on EC5026

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study)
EC5026 oral tablet, Placebo - Parkinson's Disease (PD)
Phase 1 / Phase 2RecruitingEicOsis Human Health Inc.182025-11-012026-07-10

Sponsors

EicOsis Human Health Inc. (1)

Countries

United States (1)

Top investigators

Lin Zhang, MD, PhD (1)  ·  William K Schmidt, PhD (1)